Drug recall
Vivelle-Dot, Transdermal System, (estradiol) 0.1 mg, 8 systems per carton (retail), 2 units per carton…
FDA recall event 31474 · Class III · Novartis Pharmaceuticals Corp.
Key facts
| Event ID | 31474 |
|---|---|
| Recall numbers | D-257-5 |
| Recalling firm | Novartis Pharmaceuticals Corp. |
| Product type | Drugs |
| Products | Vivelle-Dot, Transdermal System, (estradiol) 0.1 mg, 8 systems per carton (retail), 2 units per carton (physician samples). Mfd. by Noven Pharmaceuticals, Inc., Miami, FL 33186. Dist. by: Novartis… |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Stability Failure |
| Initiation date | Mar 24, 2005 |
| City | East Hanover |
| Country | United States |
| FEI number | 2210396 |
At a glance
- 1–9 Products in this recall
- None FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports